On 9 December 2014 a law substantially amending Federal Law No. 61-FZ “On Circulation of Medicines” dated 12 April 2010 (the “Law”) was adopted, in its third reading, by the State Duma of the Russian Federation.
These new amendments made to the Law (the “Amendments”) are the most significant amendments since the Law first came into force in 2010. They not only have the purpose of clarifying the Law’s conceptual framework by eliminating some of its shortcomings and improving the rules for the registration, manufacture and quality control of medicines, but also, to some extent
This webinar is devoted to critical design and process aspects of Clinical Trial Supply in Russia that is considered to be one the fastest-growing clinical trial markets while maintaining a very high level of data quality. Meanwhile clinical logistics in this region should be adapted in accordance with complex temperature conditions and special legislation...